News Qiagen N.V.

Equities

QGEN

NL0015002CX3

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:02 2025-11-14 pm EST			5-day change	1st Jan Change
44.32 ^USD	-0.74%		+1.74%	-3.24%

Nov. 11	QIAGEN NV : Deutsche Bank reiterates its Buy rating	ZD
Nov. 11	QIAGEN NV : DZ Bank reiterates its Buy rating	ZD

Pryor Cashman Represents Soleus Capital In Sale Of Parse Biosciences To QIAGEN N.V. For Up To $280 Million	Nov. 13	AQ
Qiagen N : Wolfe Research Healthcare Conference 2025 Investor Introduction	Nov. 11	PU
QIAGEN NV : Deutsche Bank reiterates its Buy rating	Nov. 11	ZD
QIAGEN NV : DZ Bank reiterates its Buy rating	Nov. 11	ZD
QIAGEN NV : Buy rating from Berenberg	Nov. 11	ZD
QIAGEN N.V. Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025	Nov. 10	CI
QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025	Nov. 10	BU
Qiagen N.V., Q3 2025 Earnings Call, Nov 05, 2025	Nov. 05
QIAGEN : Another operational beat; adjusted EPS guidance upgraded	Nov. 05
Déjà Vu, With Better Balance Sheets	Nov. 05
Qiagen N : hoc Announcement according to Art. 17 Market Abuse Regulation	Nov. 05	PU
QIAGEN NV : Deutsche Bank reiterates its Buy rating	Nov. 05	ZD
QIAGEN NV : UBS remains Neutral	Nov. 05	ZD
QIAGEN NV : Jefferies reiterates its Buy rating	Nov. 05	ZD
Qiagen N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	Nov. 04	CI
Qiagen: Q3 Earnings Snapshot	Nov. 04	AQ
Qiagen N.V. Announces to Step Down of Thierry Bernard as CEO	Nov. 04	CI
Qiagen N.V. Reaffirms Earnings Guidance for the Fiscal Year 2025	Nov. 04	CI
(QGEN) QIAGEN Expects Q4 Adjusted EPS $0.60, vs. FactSet Est of $0.61	Nov. 04	MT
Qiagen to Acquire Parse Biosciences for Up to $280 Million to Expand Single-Cell Portfolio	Nov. 04	MT
(QGEN) QIAGEN Revises Full Year 2025 Adjusted EPS Outlook To About $2.38, vs. FactSet Est of $2.34	Nov. 04	MT
Earnings Flash (QGEN) QIAGEN Posts Q3 Revenue $533M, vs. FactSet Est of $525.9M	Nov. 04	MT
Qiagen Q3 Adjusted Earnings, Revenue Rise; 2025 Adjusted EPS Guidance Boosted	Nov. 04	MT
Earnings Flash (QGEN) QIAGEN Posts Q3 Adjusted EPS $0.61, vs. FactSet Est of $0.59	Nov. 04	MT
Trading in Qiagen Shares Halted, Pending Material News Release	Nov. 04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

QIAGEN : Another operational beat; adjusted EPS guidance upgraded

November 05, 2025 at 09:14 am EST